These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 24038660

  • 1. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells.
    Saito N, Fu J, Zheng S, Yao J, Wang S, Liu DD, Yuan Y, Sulman EP, Lang FF, Colman H, Verhaak RG, Yung WK, Koul D.
    Stem Cells; 2014 Jan; 32(1):301-12. PubMed ID: 24038660
    [Abstract] [Full Text] [Related]

  • 2. Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch.
    Floyd DH, Kefas B, Seleverstov O, Mykhaylyk O, Dominguez C, Comeau L, Plank C, Purow B.
    Neuro Oncol; 2012 Oct; 14(10):1215-26. PubMed ID: 22962413
    [Abstract] [Full Text] [Related]

  • 3. Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation.
    Dell'albani P, Rodolico M, Pellitteri R, Tricarichi E, Torrisi SA, D'Antoni S, Zappia M, Albanese V, Caltabiano R, Platania N, Aronica E, Catania MV.
    Neuro Oncol; 2014 Jan; 16(2):204-16. PubMed ID: 24305720
    [Abstract] [Full Text] [Related]

  • 4. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
    Yi L, Zhou X, Li T, Liu P, Hai L, Tong L, Ma H, Tao Z, Xie Y, Zhang C, Yu S, Yang X.
    J Exp Clin Cancer Res; 2019 Aug 05; 38(1):339. PubMed ID: 31382985
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of the NOTCH pathway using γ-secretase inhibitor RO4929097 has limited antitumor activity in established glial tumors.
    Dantas-Barbosa C, Bergthold G, Daudigeos-Dubus E, Blockus H, Boylan JF, Ferreira C, Puget S, Abely M, Vassal G, Grill J, Geoerger B.
    Anticancer Drugs; 2015 Mar 05; 26(3):272-83. PubMed ID: 25486598
    [Abstract] [Full Text] [Related]

  • 6. Gamma-secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers.
    Konishi J, Kawaguchi KS, Vo H, Haruki N, Gonzalez A, Carbone DP, Dang TP.
    Cancer Res; 2007 Sep 01; 67(17):8051-7. PubMed ID: 17804716
    [Abstract] [Full Text] [Related]

  • 7. Gamma-Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt-Beta-Catenin Pathways in CD44+ Gastric Cancer Stem Cells.
    Barat S, Chen X, Cuong Bui K, Bozko P, Götze J, Christgen M, Krech T, Malek NP, Plentz RR.
    Stem Cells Transl Med; 2017 Mar 01; 6(3):819-829. PubMed ID: 28186678
    [Abstract] [Full Text] [Related]

  • 8. Oncolytic HSV-Infected Glioma Cells Activate NOTCH in Adjacent Tumor Cells Sensitizing Tumors to Gamma Secretase Inhibition.
    Otani Y, Yoo JY, Chao S, Liu J, Jaime-Ramirez AC, Lee TJ, Hurwitz B, Yan Y, Dai H, Glorioso JC, Caligiuri MA, Yu J, Kaur B.
    Clin Cancer Res; 2020 May 15; 26(10):2381-2392. PubMed ID: 32139403
    [Abstract] [Full Text] [Related]

  • 9. Level of Notch activation determines the effect on growth and stem cell-like features in glioblastoma multiforme neurosphere cultures.
    Kristoffersen K, Villingshøj M, Poulsen HS, Stockhausen MT.
    Cancer Biol Ther; 2013 Jul 15; 14(7):625-37. PubMed ID: 23792644
    [Abstract] [Full Text] [Related]

  • 10. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.
    Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG.
    Stem Cells; 2010 Jan 15; 28(1):5-16. PubMed ID: 19904829
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dose-dependent proteomic analysis of glioblastoma cancer stem cells upon treatment with γ-secretase inhibitor.
    Dai L, He J, Liu Y, Byun J, Vivekanandan A, Pennathur S, Fan X, Lubman DM.
    Proteomics; 2011 Dec 15; 11(23):4529-40. PubMed ID: 21932445
    [Abstract] [Full Text] [Related]

  • 14. A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma.
    Herrera-Rios D, Li G, Khan D, Tsiampali J, Nickel AC, Aretz P, Hewera M, Suwala AK, Jiang T, Steiger HJ, Kamp MA, Muhammad S, Hänggi D, Maciaczyk J, Zhang W, Kahlert UD.
    Sci Rep; 2020 Oct 01; 10(1):16218. PubMed ID: 33004830
    [Abstract] [Full Text] [Related]

  • 15. Crosstalk between glioma-initiating cells and endothelial cells drives tumor progression.
    Jeon HM, Kim SH, Jin X, Park JB, Kim SH, Joshi K, Nakano I, Kim H.
    Cancer Res; 2014 Aug 15; 74(16):4482-92. PubMed ID: 24962027
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. miR-33a promotes glioma-initiating cell self-renewal via PKA and NOTCH pathways.
    Wang H, Sun T, Hu J, Zhang R, Rao Y, Wang S, Chen R, McLendon RE, Friedman AH, Keir ST, Bigner DD, Li QJ, Wang H, Wang XF.
    J Clin Invest; 2014 Oct 15; 124(10):4489-502. PubMed ID: 25202981
    [Abstract] [Full Text] [Related]

  • 20. Notch Signaling in Breast Cancer: A Role in Drug Resistance.
    BeLow M, Osipo C.
    Cells; 2020 Sep 29; 9(10):. PubMed ID: 33003540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.